Clinical Trials Study
Copyright ©The Author(s) 2024.
World J Clin Oncol. Sep 24, 2024; 15(9): 1177-1187
Published online Sep 24, 2024. doi: 10.5306/wjco.v15.i9.1177
Figure 1
Figure 1 Flow diagram of selection of eligible patients. OBBT: Overt bleeding before treatment.
Figure 2
Figure 2 Kaplan Meier curves of overall survival. A: Overall survival (OS) of gastric cancer (GC)/gastroesophageal junction cancer (GEJC) patients according to overt bleeding before treatment; B: OS of GC/GEJC patients according to overt bleeding after treatment. OBBT: Overt bleeding before treatment; OBAT: Overt bleeding after treatment; mOS: Median overall survival.